Genmab (GMAB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist

20.650
+0.180+0.88%

Close Nov 22 16:00 ET

20.650
0.0000.00%

Post 20:01 ET

13.12BMarket Cap20.32P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
Yahoo FinanceNov 21 17:21 ET
Genmab Aligns Employee Incentives With Stock Units
TipRanksNov 21 15:17 ET
Grant of Restricted Stock Units and Warrants to Employees in Genmab
GlobeNewswireNov 21 14:48 ET
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Seeking AlphaNov 21 10:20 ET
Top Gap Ups and Downs on Tuesday: SMCI, WMT, BBY and More
Moomoo NewsNov 19 18:43 ET · Markets
Truist Financial Maintains Genmab(GMAB.US) With Buy Rating
Moomoo NewsNov 19 03:36 ET · Ratings

Comments

Stock_Drift

Sep 15 09:58

$Genmab (GMAB.US)$

亿顺利发春2888

Jul 12 08:38

$Genmab (GMAB.US)$ growth up positive trend

亿顺利发春2888

Jul 11 08:53

$Genmab (GMAB.US)$ positive growth $26, growth upwards trend

亿顺利发春2888

Jul 10 15:28

$Genmab (GMAB.US)$ growth is very slow

Meltyy

Jun 28 02:47

$Genmab (GMAB.US)$ $AbbVie (ABBV.US)$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

GMAB Genmab

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target